Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, BioAge Labs Inc (NASDAQ: BIOA) closed at $4.39 up 0.92% from its previous closing price of $4.35. In other words, the price has increased by $0.92 from its previous closing price. On the day, 0.36 million shares were traded.
Ratios:
For a deeper understanding of BioAge Labs Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.68 and its Current Ratio is at 13.68. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 10, 2024, Morgan Stanley Downgraded its rating to Underweight which previously was Overweight and also lowered its target price recommendation from $40 to $5.
Jefferies Downgraded its Buy to Hold on December 09, 2024, whereas the target price for the stock was revised from $42 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 27 ’24 when Barton Shane bought 2,632 shares for $18.00 per share. The transaction valued at 47,376 led to the insider holds 2,632 shares of the business.
Pande Vijay Satyanand bought 126,793 shares of BIOA for $2,501,626 on Oct 01 ’24. The Director now owns 1,026,793 shares after completing the transaction at $19.73 per share. On Oct 02 ’24, another insider, Pande Vijay Satyanand, who serves as the Director of the company, bought 67,096 shares for $19.73 each. As a result, the insider paid 1,323,804 and bolstered with 1,093,889 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOA now has a Market Capitalization of 157381488. For the stock, the TTM Price-to-Sale (P/S) ratio is 108.54 while its Price-to-Book (P/B) ratio in mrq is 0.50.
Stock Price History:
Over the past 52 weeks, BIOA has reached a high of $26.62, while it has fallen to a 52-week low of $2.88. The 50-Day Moving Average of the stock is 8.29%, while the 200-Day Moving Average is calculated to be -51.89%.
Shares Statistics:
A total of 35.85M shares are outstanding, with a floating share count of 21.05M. Insiders hold about 41.29% of the company’s shares, while institutions hold 32.33% stake in the company.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
